Christian Weyer, EVP, Research & Development at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 1,446 shares at $94.04 ($136K) on 2020-01-27, disclosed to the SEC on 2020-01-27.
Open-market sale of $136k ICPT by EVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.04 | 723 | $68K | 50.0% |
| 2 | $94.04 | 723 | $68K | 50.0% |
| Total | $94.04 avg | 1,446 | $136K | 100% |
| Filing → |
| ICPT | SELL | 2019-12-30 | $390K | — | Filing → |
| ICPT | SELL | 2019-12-02 | $106K | — | Filing → |
| ICPT | SELL | 2019-11-27 | $623K | — | Filing → |